All data are based on the daily closing price as of November 11, 2026
y

Yuhan

000100.KO
59.18 USD
0.43
+0.73%

Overview

Last close
59.18 usd
Market cap
4.36B usd
52 week high
97.67 usd
52 week low
43.25 usd
Target price
83.94 usd

Valuation

P/E
25.1031
Forward P/E
15.7978
Price/Sales
2.5879
Price/Book Value
2.4628
Enterprise Value
4.32B usd
EV/Revenue
2.5257
EV/EBITDA
15.7246

Key financials

Revenue TTM
1.71B usd
Gross Profit TTM
567.89M usd
EBITDA TTM
151.71M usd
Earnings per Share
2.35 usd
Dividend
0.45 usd
Total assets
2.15B usd
Net debt
N/A usd

About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
  • Symbol
    000100.KO
  • Exchange
    KO
  • Isin
    KR7000100008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Wook-Je Cho
  • Headquarter
    Seoul
  • Web site
    https://www.yuhan.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top